Top

Drugs & Therapy Perspectives

Published in:

01-02-2015 | Original Research Article

Do physicians communicate the adverse effects of medications that older patients want to hear?

Authors: Derjung M. Tarn, Ariela Wenger, Jeffrey S. Good, Marc Hoffing, Joseph E. Scherger, Neil S. Wenger

Published in: Drugs & Therapy Perspectives | Issue 2/2015

Abstract

Background and objectives

Physicians routinely discuss the adverse effects of medications but whether these discussions match older patients’ desire for information is an area that has not been explored. This study compares patient preferences for adverse effect discussions with reported physician practice.

Methods

A cross-sectional survey of a convenience sample of 100 practicing primary care physicians from nine medical groups, and 178 patients recruited from 11 senior centers in the Los Angeles metropolitan area. Physicians listed the adverse effects they typically discuss when prescribing an ACE inhibitor. Patients were given a hypothetical scenario about a new medication prescription and, from a list of adverse effects, they were then asked to circle the three they most wanted to hear about.

Results

More than 90 % of patients wanted a physician to discuss medication adverse effects; they wanted information about both dangerous (75 % of patients) and common (66 % of patients) adverse effects. However, patients most commonly chose to hear about adverse effects occurring for <1 % of patients, and selected a wide range of adverse effects for discussion. Physicians most frequently reported educating patients about adverse effects which were more common and life-threatening. Patients wishing to discuss additional adverse effects were more worried about adverse effects than those wishing to hear fewer (4.0 vs. 3.4 on a 5-point Likert scale; p = 0.02).

Conclusions

For the studied medication, there was little concordance between the medication adverse effects physicians say they discuss and what patients want to hear. Physicians cannot practically verbally satisfy patients’ information desires about the adverse effects of new medications during time-compressed office visits. Innovative solutions are needed.

Available only for authorised users

National Center for Health Statistics. Health, United States, 2011: with special feature on socioeconomic status and health [Table 99]. Hyattsville (MD). US Department of Health and Human Services; 2012.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5.PubMedCrossRef

Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55(Suppl 2):S373–82.PubMedCrossRef

AHRQ. Questions are the answer. Agency for Healthcare Research and Quality, Rockville (MD). Available from: http://www.ahrq.gov/questionsaretheanswer/level3col_1.asp?nav=3colNav05&content=05_0_prescription. Accessed 27 Dec 2012.

Aspden P, Institute of Medicine (US). Committee on Identifying and Preventing Medication Errors. Preventing medication errors. Quality chasm series. Washington, DC: National Academies Press; 2007. Available from: https://libproxy.usc.edu/login?url=http://ZB5LH7ED7A.search.serialssolutions.com/?V=1.0&L=ZB5LH7ED7A&S=JCs&C=TC0000226812&T=marc.

Huang SW. The Omnibus Reconciliation Act of 1990: redefining pharmacists’ legal responsibilities. Am J Law Med. 1998;24(4):417–42.PubMed

Nair K, Dolovich L, Cassels A, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104–10.PubMedCentralPubMed

Lisper L, Isacson D, Sjoden PO, Bingefors K. Medicated hypertensive patients’ views and experience of information and communication concerning antihypertensive drugs. Patient Educ Couns. 1997;32(3):147–55.PubMedCrossRef

Ziegler DK, Mosier MC, Buenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med. 2001;161(5):706–13.PubMedCrossRef

10.

Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288(11):1403–9.PubMedCrossRef

11.

Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166(17):1855–62.PubMedCrossRef

12.

MacLean CH. Quality indicators for the management of osteoarthritis in vulnerable elders. Ann Intern Med. 2001;135(8 Pt 2):711–21.PubMedCrossRef

13.

Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.PubMed

14.

Powers BJ, Trinh JV, Bosworth HB. Can this patient read and understand written health information? JAMA. 2010;304(1):76–84.PubMedCrossRef

15.

Mechanic D. How should hamsters run? Some observations about sufficient patient time in primary care. BMJ. 2001;323(7307):266–8.PubMedCentralPubMedCrossRef

16.

Dickinson D, Raynor DK. What information do patients need about medicines? Ask the patients—they may want to know more than you think. BMJ. 2003;327(7419):861.PubMedCentralPubMedCrossRef

17.

Unni E, Farris KB. Determinants of different types of medication non-adherence in cholesterol lowering and asthma maintenance medications: a theoretical approach. Patient Educ Couns. 2011;83(3):382–90.PubMedCrossRef

18.

Duke J, Friedlin J, Ryan P. A quantitative analysis of adverse events and “overwarning” in drug labeling. Arch Intern Med. 2011;171(10):944–6.PubMedCrossRef

Title: Do physicians communicate the adverse effects of medications that older patients want to hear?
Authors: Derjung M. Tarn
Ariela Wenger
Jeffrey S. Good
Marc Hoffing
Joseph E. Scherger
Neil S. Wenger
Publication date: 01-02-2015
Publisher: Springer International Publishing
Published in: Drugs & Therapy Perspectives / Issue 2/2015
Print ISSN: 1172-0360
Electronic ISSN: 1179-1977
DOI: https://doi.org/10.1007/s40267-014-0176-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Do physicians communicate the adverse effects of medications that older patients want to hear?

Abstract

Background and objectives

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2015

First reports of serious adverse drug reactions in recent weeks

Consider behavioural strategies in addition to antidepressants in clinically depressed patients with chronic obstructive pulmonary disease

Tiotropium Respimat® Soft Mist™ inhaler: a guide to its use in chronic obstructive pulmonary disease (COPD) in the EU

Initiate antibacterial treatment early in patients with carbapenem-resistant or extensively drug-resistant Acinetobacter baumannii infection

Imatinib: a guide to its use as adjuvant therapy for gastrointestinal stromal tumour (GIST) in the EU

Functional oesophageal disorders must be diagnosed properly and treated accordingly